ABsize is a bioventure specializing in nanotechnology and nanomedicine spun off by Osaka University. U.S. Phase I trials could be started by the end of the year, followed by an ABsize search for a partner to carry the patch to Phase II trials and beyond. ABsize is aiming for a 2013 U.S. launch of its patch. (Click here for more – a subscription may be required
)